Related Experiment Videos
Simplified identification of Lynch syndrome: a prospective, multicenter study
Delphine Bonnet1, Janick Selves, Christine Toulas
1Purpan Hospital, Medical Oncology, Institut Claudius Regaud, Medical Genetics, Cancer Research Centre of Toulouse, INSERM UMR 1037/CNRS-ERL 5294/Toulouse 3 University, Markers & Targets for Digestive Cancer Biotherapy, Toulouse, France.
Summary
A new strategy using simple clinical criteria and tumor testing effectively identifies Lynch syndrome carriers in colorectal cancer patients. This approach improves diagnosis rates for Lynch syndrome outside specialized centers.
Area of Science:
- Oncology
- Genetics
- Cancer Screening
Background:
- Current Lynch syndrome screening strategies for colorectal cancer are underutilized in clinical practice.
- This leads to a significant number of Lynch syndrome cases remaining undiagnosed.
Purpose of the Study:
- To evaluate a practical strategy for identifying Lynch syndrome carriers in routine colorectal cancer care.
- The strategy combines simplified clinical criteria with molecular testing for Mismatch Repair deficiency.
Main Methods:
- Colorectal cancer patients meeting specific criteria (age <50, personal/family history of specific cancers) were included.
- Tumor samples underwent Mismatch Repair deficiency testing (microsatellite instability and immunohistochemistry).
- Patients with deficient tumors were offered germline genetic testing.
Main Results:
- Out of 307 patients meeting criteria, 46 (15%) had Mismatch Repair-deficient tumors.
- Twenty-seven Lynch syndrome carriers were identified, including 20 with confirmed germline mutations.
- The Mismatch Repair-deficient status in this selected group was highly predictive (59%) of Lynch syndrome.
Conclusions:
- A bio-clinical strategy using simplified criteria and Mismatch Repair testing efficiently detects Lynch syndrome cases.
- This approach is practical and applicable in non-expert clinical settings.
- Improved detection can lead to better management and hereditary cancer prevention.